α-synuclein amino terminus regulates mitochondrial membrane permeability

Brain Research

Volumn 1591, Issue 1, 2014, Pages 14-26

  Shen, Jiamei ^a   Du, Tingting ^a   Wang, Xue ^a   Duan, Chunli ^a   Gao, Ge ^a   Zhang, Jianliang ^a   Lu, Lingling ^a   Yang, Hui ^a  

^a BEIJING INSTITUTE FOR BRAIN DISORDERS   (China)

Author keywords

Mitochondrial membrane permeability; Parkinson's disease; Reactive oxygen species; synuclein; synuclein N terminus

Indexed keywords

ALPHA SYNUCLEIN; BONGKREKIC ACID; CARDIOLIPIN; LACTATE DEHYDROGENASE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; REACTIVE OXYGEN METABOLITE; VOLTAGE DEPENDENT ANION CHANNEL;

AMINO TERMINAL SEQUENCE; ARTICLE; BRAIN CELL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; ENZYME RELEASE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MOLECULAR WEIGHT; MTT ASSAY; NERVE CELL CULTURE; NERVE DEGENERATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CELL MEMBRANE PERMEABILITY; METABOLISM; MITOCHONDRION; NERVE CELL; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ALPHA-SYNUCLEIN; ANIMALS; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; NEURONS; PARKINSON DISEASE; RATS, SPRAGUE-DAWLEY;

EID: 84922546589     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2014.09.046     Document Type: Article

References (55)

1. Alim, M.A., Ma, Q.L., Takeda, K., Aizawa, T., Matsubara, M., Nakamura, M., Asada, A., Saito, T., Kaji, H., Yoshii, M., Hisanaga, S., Ueda, K., 2004. Demonstration of a role for alphasynuclein as a functional microtubule-associated protein. J. Alzheimers Dis. 6, 435-442 (discussion 443-449).
2. Anderson, M.F., Sims, N.R., 2000. Improved recovery of highly enriched mitochondrial fractions from small brain tissue samples. Brain Res. Brain Res. Protoc. 5, 95-101.
3. Banerjee, K., Sinha, M., Pham, C.L., Jana, S., Chanda, D., Cappai, R., Chakrabarti, S., 2010a. Alpha-synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: implications in Parkinson's disease. FEBS Lett. 584, 1571-1576.
4. Banerjee, K., Sinha, M., Pham, C.L., Jana, S., Chanda, D., Cappai, R., Chakrabarti, S., 2010b. Alpha-synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: implications in Parkinson's disease. FEBS Lett. 584, 1571-1576.
5. Barrett, L.E., Van Bockstaele, E.J., Sul, J.Y., Takano, H., Haydon, P.G., Eberwine, J.H., 2006. Elk-1 associates with the mitochondrial permeability transition pore complex in neurons. Proc. Natl. Acad. Sci. USA 103, 5155-5160.
6. Bueler, H., 2009. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Exp. Neurol. 218, 235-246.
7. Buttner, S., Bitto, A., Ring, J., Augsten, M., Zabrocki, P., Eisenberg, T., Jungwirth, H., Hutter, S., Carmona-Gutierrez, D., Kroemer, G., Winderickx, J., Madeo, F., 2008. Functional mitochondria are required for alpha-synuclein toxicity in aging yeast. J. Biol. Chem. 283, 7554-7560.
8. Chinta, S.J., Mallajosyula, J.K., Rane, A., Andersen, J.K., 2010a. Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci. Lett. 486, 235-239.
9. Chinta, S.J., Mallajosyula, J.K., Rane, A., Andersen, J.K., 2010b. Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci. Lett. 486, 235-239.
10. Chu, C.T., Ji, J., Dagda, R.K., Jiang, J.F., Tyurina, Y.Y., Kapralov, A.A., Tyurin, V.A., Yanamala, N., Shrivastava, I.H., Mohammadyani, D., Qiang,W.K., Zhu, J., Klein-Seetharaman, J., Balasubramanian, K., Amoscato, A.A., Borisenko, G., Huang, Z., Gusdon, A.M., Cheikhi, A., Steer, E.K., Wang, R., Baty, C., Watkins, S., Bahar, I., Bayir, H., Kagan, V.E., 2013. Cardiolipin externalization to the outermitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. Nat. Cell Biol. 15, 1197-1205.
11. Da, S.F., Coelho, C.E., de Freitas, M.S., Goncalves, D.L., Costa, L.T., Follmer, C., 2013. Vitamins K interact with N-terminus alpha-synuclein and modulate the protein fibrillization in vitro. Exploring the interaction between quinones and alpha-synuclein. Neurochem. Int. 62, 103-112.
12. Dagda, R.K., Zhu, J., Chu, C.T., 2009. Mitochondrial kinases in Parkinson's disease: converging insights from neurotoxin and genetic models. Mitochondrion 9, 289-298.
13. Dev, K.K., Hofele, K., Barbieri, S., Buchman, V.L., van der Putten, H., 2003. Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease. Neuropharmacology 45, 14-44.
14. Devi, L., Raghavendran, V., Prabhu, B.M., Avadhani, N.G., Anandatheerthavarada, H.K., 2008. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J. Biol. Chem. 283, 9089-9100.
15. Dias, V., Junn, E., Mouradian, M.M., 2013. The role of oxidative stress in Parkinson's disease. J. Parkinsons Dis. 3, 461-491.
16. Exner, N., Lutz, A.K., Haass, C., Winklhofer, K.F., 2012. Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences. EMBO J. 31, 3038-3062.
17. Feany, M.B., Bender, W.W., 2000. A Drosophila model of Parkinson's disease. Nature 404, 394-398.
18. Feng, L.R., Federoff, H.J., Vicini, S., Maguire-Zeiss, K.A., 2010. Alpha-synuclein mediates alterations in membrane conductance: a potential role for alpha-synuclein oligomers in cell vulnerability. Eur. J. Neurosci. 32, 10-17.
19. Halestrap, A.P., 2009. What is the mitochondrial permeability transition pore?. J. Mol. Cell. Cardiol. 46, 821-831.
20. Houtkooper, R.H., Vaz, F.M., 2008. Cardiolipin, the heart of mitochondrial metabolism. Cell. Mol. Life Sci. 65, 2493-2506.
21. Hsu, L.J., Sagara, Y., Arroyo, A., Rockenstein, E., Sisk, A., Mallory, M., Wong, J., Takenouchi, T., Hashimoto, M., Masliah, E., 2000. Alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am. J. Pathol. 157, 401-410.
22. Junn, E., Mouradian, M.M., 2002. Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine. Neurosci. Lett. 320, 146-150.
23. Klingenberg, M., 2009a. Cardiolipin and mitochondrial carriers. Biochim. Biophys. Acta 1788, 2048-2058.
24. Klingenberg, M., 2009b. Cardiolipin and mitochondrial carriers. Biochim Biophys. Acta 1788, 2048-2058.
25. Lin, T.K., Liou, C.W., Chen, S.D., Chuang, Y.C., Tiao, M.M., Wang, P.W., Chen, J.B., Chuang, J.H., 2009. Mitochondrial dysfunction and biogenesis in the pathogenesis of Parkinson's disease. Chang Gung Med. J. 32, 589-599.
26. Lippa, C.F., Fujiwara, H., Mann, D.M., Giasson, B., Baba, M., Schmidt, M.L., Nee, L.E., O'Connell, B., Pollen, D.A., St, G.P., Ghetti, B., Nochlin, D., Bird, T.D., Cairns, N.J., Lee, V.M., Iwatsubo, T., Trojanowski, J.Q., 1998. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am. J. Pathol. 153, 1365-1370.
27. Liu, G., Zhang, C., Yin, J., Li, X., Cheng, F., Li, Y., Yang, H., Ueda, K., Chan, P., Yu, S., 2009. alpha-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity. Neurosci. Lett. 454, 187-192.
28. Lu, L., Zhang, C., Cai, Q., Lu, Q., Duan, C., Zhu, Y., Yang, H., 2013. Voltage-dependent anion channel involved in the alpha-synuclein-induced dopaminergic neuron toxicity in rats. Acta Biochim. Biophys. Sin (Shanghai) 45, 170-178.
29. Lynch-Day, M.A., Mao, K., Wang, K., Zhao, M., Klionsky, D.J., 2012. The role of autophagy in Parkinson's disease. Cold Spring Harb. Perspect. Med. 2, a009357.
30. Martin, L.J., Pan, Y., Price, A.C., Sterling, W., Copeland, N.G., Jenkins, N.A., Price, D.L., Lee, M.K., 2006. Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J. Neurosci. 26, 41-50.
31. Martin, L.J., Semenkow, S., Hanaford, A., Wong, M., 2013. The mitochondrial permeability transition pore regulates Parkinson's disease development in mutant alpha-synuclein transgenic mice. Neurobiol. Aging.
32. Martinou, J.C., Green, D.R., 2001a. Breaking the mitochondrial barrier. Nat. Rev. Mol. Cell. Biol. 2, 63-67.
33. Martinou, J.C., Green, D.R., 2001b. Breaking the mitochondrial barrier. Nat. Rev. Mol. Cell. Biol. 2, 63-67.
34. Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., Mucke, L., 2000. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265-1269.
35. Nakamura, K., Nemani, V.M., Wallender, E.K., Kaehlcke, K., Ott, M., Edwards, R.H., 2008. Optical reporters for the conformation of alpha-synuclein reveal a specific interaction with mitochondria. J. Neurosci. 28, 12305-12317.
36. Orth, M., Tabrizi, S.J., Schapira, A.H., Cooper, J.M., 2003. Alpha-synuclein expression in HEK293 cells enhances the mitochondrial sensitivity to rotenone. Neurosci. Lett. 351, 29-32.
37. Pacheco, C., Aguayo, L.G., Opazo, C., 2012. An extracellular mechanism that can explain the neurotoxic effects of alphasynuclein aggregates in the brain. Front. Physiol. 3, 297.
38. Paradies, G., Paradies, V., Ruggiero, F.M., Petrosillo, G., 2013. Cardiolipin and mitochondrial function in health and disease. Antioxid. Redox Signal.
39. Parihar, M.S., Parihar, A., Fujita, M., Hashimoto, M., Ghafourifar, P., 2009a. Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells. Int. J. Biochem. Cell. Biol. 41, 2015-2024.
40. Parihar, M.S., Parihar, A., Fujita, M., Hashimoto, M., Ghafourifar, P., 2009b. Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells. Int. J. Biochem. Cell. Biol. 41, 2015-2024.
41. Petit, J.M., Maftah, A., Ratinaud, M.H., Julien, R., 1992. 10 N-nonyl acridine orange interacts with cardiolipin and allows the quantification of this phospholipid in isolated mitochondria. Eur. J. Biochem. 209, 267-273.
42. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E.S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W.G., Lazzarini, A.M., Duvoisin, R.C., Di Iorio, G., Golbe, L.I., Nussbaum, R.L., 1997. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047.
43. Rival, T., Macchi, M., Arnaune-Pelloquin, L., Poidevin, M., Maillet, F., Richard, F., Fatmi, A., Belenguer, P., Royet, J., 2011. Innermembrane proteins PMI/TMEM11 regulate mitochondrial morphogenesis independently of the DRP1/MFN fission/fusion pathways. EMBO Rep. 12, 223-230.
44. Sarafian, T.A., Ryan, C.M., Souda, P., Masliah, E., Kar, U.K., Vinters, H.V., Mathern, G.W., Faull, K.F., Whitelegge, J.P., Watson, J.B., 2013. Impairment of mitochondria in adult mouse brain overexpressing predominantly full-length, N-terminally acetylated human alpha-synuclein. PLoS One 8, e63557.
45. Schmidt, S., Linnartz, B., Mendritzki, S., Sczepan, T., Lubbert, M., Stichel, C.C., Lubbert, H., 2011. Genetic mouse models for Parkinson's disease display severe pathology in glial cell mitochondria. Hum. Mol. Genet. 20, 1197-1211.
46. Shults, C.W., 2006. Lewy bodies. Proc. Natl. Acad. Sci. USA 103, 1661-1668.
47. Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., Lincoln, S., Crawley, A., Hanson, M., Maraganore, D., Adler, C., Cookson, M.R., Muenter, M., Baptista, M., Miller, D., Blancato, J., Hardy, J., Gwinn-Hardy, K., 2003. alpha-Synuclein locus triplication causes Parkinson's disease. Science 302, 841.
48. Song, D.D., Shults, C.W., Sisk, A., Rockenstein, E., Masliah, E., 2004. Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp. Neurol. 186, 158-172.
49. Williams, G.C., Liu, A., Knipp, G., Sinko, P.J., 2002. Direct evidence that saquinavir is transported by multidrug resistanceassociated protein (MRP1) and canalicular multispecific organic anion transporter (MRP2). Antimicrob. Agents Chemother. 46, 3456-3462.
50. Yang, W., Wang, X., Duan, C., Lu, L., Yang, H., 2013a. Alphasynuclein overexpression increases phospho-protein phosphatase 2A levels via formation of calmodulin/Src complex. Neurochem. Int. 63, 180-194.
51. Yang, W., Wang, X., Duan, C., Lu, L., Yang, H., 2013b. Alphasynuclein overexpression increases phospho-protein phosphatase 2A levels via formation of calmodulin/Src complex. Neurochem. Int. 63, 180-194.
52. Yu, S., Li, X., Liu, G., Han, J., Zhang, C., Li, Y., Xu, S., Liu, C., Gao, Y., Yang, H., Ueda, K., Chan, P., 2007. Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody. Neuroscience 145, 539-555.
53. Zarranz, J.J., Alegre, J., Gomez-Esteban, J.C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atares, B., Llorens, V., Gomez, T.E., Del, S.T., Munoz, D.G., de Yebenes, J.G., 2004. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164-173.
54. Zhang, Y., Ma, H., Xie, B., Han, C., Wang, C., Qing, H., Deng, Y., 2013. Alpha-synuclein overexpression induced mitochondrial damage by the generation of endogenous neurotoxins in PC12 cells. Neurosci. Lett. 547, 65-69.
55. Zhu, Y., Duan, C., Lu, L., Gao, H., Zhao, C., Yu, S., Ueda, K., Chan, P., Yang, H., 2011. alpha-Synuclein overexpression impairs mitochondrial function by associating with adenylate translocator. Int. J. Biochem. Cell. Biol. 43, 732-741.